tiprankstipranks
Advertisement
Advertisement

PFE Stock Latest News

CMS proposes to lock in lower prices in Medicare drug price negotiation program
The FlyCMS proposes to lock in lower prices in Medicare drug price negotiation program
21h ago
AZN
BMY
Pfizer Pivots Hard: Obesity, Cancer Bets Tempt Investors
PremiumWeekend Updates
Pfizer Pivots Hard: Obesity, Cancer Bets Tempt Investors
3d ago
PFE
Pfizer Targets Gastric Cancer Growth With New PF-08634404 Combo Trial
PremiumCompany Announcements
Pfizer Targets Gastric Cancer Growth With New PF-08634404 Combo Trial
4d ago
PFE
Moderately bullish activity in Pfizer with shares up 2.21%
PremiumThe Fly
Moderately bullish activity in Pfizer with shares up 2.21%
5d ago
PFE
Pfizer’s New Phase 1 PF-07799544 Study Adds Quiet Depth to Its R&D Pipeline
PremiumCompany Announcements
Pfizer’s New Phase 1 PF-07799544 Study Adds Quiet Depth to Its R&D Pipeline
5d ago
PFE
Unusually active option classes on open June 11th
PremiumThe FlyUnusually active option classes on open June 11th
5d ago
AMC
PBR
Pfizer Steps Up in Obesity Race With New Mid-Stage SOLIS-1 Trial
Premium
Company Announcements
Pfizer Steps Up in Obesity Race With New Mid-Stage SOLIS-1 Trial
6d ago
PFE
Pfizer’s Next-Gen Pneumococcal Shot: What a Fresh Trial Update Means for PFE Investors
Premium
Company Announcements
Pfizer’s Next-Gen Pneumococcal Shot: What a Fresh Trial Update Means for PFE Investors
6d ago
PFE
Pfizer upgraded to Sector Perform from Underperform at RBC Capital
PremiumThe Fly
Pfizer upgraded to Sector Perform from Underperform at RBC Capital
7d ago
PFE
Pfizer upgraded to Sector Perform at RBC Capital amid more balanced risk-reward
PremiumThe Fly
Pfizer upgraded to Sector Perform at RBC Capital amid more balanced risk-reward
7d ago
PFE
Pfizer Obesity Franchise Shows Promise but Competition, Execution Risks Keep Rating at Hold and Price Target Unchanged at $26
PremiumRatings
Pfizer Obesity Franchise Shows Promise but Competition, Execution Risks Keep Rating at Hold and Price Target Unchanged at $26
7d ago
PFE
Pfizer-Backed EV-309 Trial Targets Bladder-Sparing Edge in Muscle-Invasive Cancer
PremiumCompany Announcements
Pfizer-Backed EV-309 Trial Targets Bladder-Sparing Edge in Muscle-Invasive Cancer
8d ago
PFE
Pfizer says FDA approves expanded indication for Hympavzi
PremiumThe FlyPfizer says FDA approves expanded indication for Hympavzi
8d ago
PFE
Pfizer presents results from Phase 2b studies of berobenatide
Premium
The Fly
Pfizer presents results from Phase 2b studies of berobenatide
9d ago
PFE
Pfizer Doubles Down on Vaccines and Cancer Ambitions
Premium
Weekend Updates
Pfizer Doubles Down on Vaccines and Cancer Ambitions
10d ago
PFE
Pfizer’s New Infant Pneumococcal Vaccine Trial: What Investors Should Watch
PremiumCompany Announcements
Pfizer’s New Infant Pneumococcal Vaccine Trial: What Investors Should Watch
11d ago
PFE
Acting FDA head vows to block political interference, Endpoint News says
PremiumThe Fly
Acting FDA head vows to block political interference, Endpoint News says
12d ago
AZN
BMY
Pfizer Expands Oncology Pipeline With New PF-08634404 Combo Trial in Advanced Lung Cancer
PremiumCompany Announcements
Pfizer Expands Oncology Pipeline With New PF-08634404 Combo Trial in Advanced Lung Cancer
12d ago
PFE
Pfizer and Astellas Advance New Bladder Cancer Combo in Early Clinical Trial
PremiumCompany Announcements
Pfizer and Astellas Advance New Bladder Cancer Combo in Early Clinical Trial
12d ago
PFE
Pfizer’s New Lung Cancer Study Signals Fresh Oncology Upside for PFE Investors
PremiumCompany AnnouncementsPfizer’s New Lung Cancer Study Signals Fresh Oncology Upside for PFE Investors
12d ago
PFE
Pfizer’s Bevacizumab Biosimilar Safety Study in Japan Reaches Completion: What Investors Should Watch
Premium
Company Announcements
Pfizer’s Bevacizumab Biosimilar Safety Study in Japan Reaches Completion: What Investors Should Watch
13d ago
PFE
Pfizer’s ODEN Study Update: Real-World Data on Tofacitinib in Ulcerative Colitis
Premium
Company Announcements
Pfizer’s ODEN Study Update: Real-World Data on Tofacitinib in Ulcerative Colitis
13d ago
PFE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >